More recently, in cohort studies of 181 CRC patients, PD-L1 expression was associated with high CD8+ tumor-infiltrating lymphocytes (TILs), BRAF mutation, microsatellite instability (MSI), lower frequency of K-ras, and poor prognosis [16]. This evidence concerns the gene CD274 and colorectal carcinoma.